Skip to main content
. 2024 Feb 29;46:89–91. doi: 10.1016/j.jdcr.2024.01.039

Fig 1.

Fig 1

Actinic prurigo response to dupilumab, patient 1. A, Patient 1 presentation in clinic with a flare refractory to mometasone, tacrolimus, and photoprotection. B, Patient 1 following treatment with mometasone, photoprotection, and 2 months of dupilumab.